Proehl Investment Ventures LLC - 17 Aug 2021 Form 4 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Role
10%+ Owner
Signature
/s/ Gerald T. Proehl, Managing Member
Issuer symbol
DRMA
Transactions as of
17 Aug 2021
Net transactions value
$0
Form type
4
Filing time
17 Aug 2021, 12:48:25 UTC
Previous filing
12 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DRMA Common Stock Conversion of derivative security +361,147 +39% 1,278,464 17 Aug 2021 Direct F1
transaction DRMA Common Stock Conversion of derivative security +111,951 +8.8% 1,390,415 17 Aug 2021 Direct F2
transaction DRMA Common Stock Conversion of derivative security +181,585 +13% 1,572,000 17 Aug 2021 Direct F3
transaction DRMA Common Stock Conversion of derivative security +1,247,904 +79% 2,819,904 17 Aug 2021 Direct F4
transaction DRMA Common Stock Conversion of derivative security +85,640 +3% 2,905,544 17 Aug 2021 Direct F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DRMA Series 1d Preferred Stock Conversion of derivative security $0 -2,436,657 -100% $0.000000* 0 17 Aug 2021 Common Stock 361,147 Direct F1
transaction DRMA Series 1a Preferred Stock Conversion of derivative security $0 -2,295,000 -100% $0.000000* 0 17 Aug 2021 Common Stock 111,951 Direct F2
transaction DRMA Series 1b Preferred Stock Conversion of derivative security $0 -3,722,500 -100% $0.000000* 0 17 Aug 2021 Common Stock 181,585 Direct F3
transaction DRMA Series 1c Preferred Stock Conversion of derivative security $0 -25,582,050 -100% $0.000000* 0 17 Aug 2021 Common Stock 1,247,904 Direct F4
transaction DRMA Series 1 Preferred Stock Conversion of derivative security $0 -1,755,622 -100% $0.000000* 0 17 Aug 2021 Common Stock 85,640 Direct F5
transaction DRMA Series 1a Warrants Conversion of derivative security $0 -573,750 -100% $0.000000* 0 17 Aug 2021 Common Stock 27,987 Direct F6
transaction DRMA Warrant to Purchase Common Stock Conversion of derivative security $0 +27,987 $0.000000 27,987 17 Aug 2021 Common Stock 27,987 $20.50 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date.
F2 The Series 1a Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1a Preferred Stock was convertible at any time and had no expiration date.
F3 The Series 1b Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1b Preferred Stock was convertible at any time and had no expiration date.
F4 The Series 1c Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1c Preferred Stock was convertible at any time and had no expiration date.
F5 The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1 Preferred Stock was convertible at any time and had no expiration date.
F6 The Series 1a Preferred Warrants converted into warrants to purchase Common Stock in connection with the IPO.